Aurobindo Pharma

Aurobindo Pharma, established in 1986 and headquartered in Hyderabad, India, is a prominent global entity specializing in the marketing and manufacturing of generic pharmaceuticals and active pharmaceutical ingredients (APIs). The company has cultivated a robust international presence, operating across multiple therapeutic areas. Its comprehensive product portfolio spans critical segments including Antibiotics, AntiRetrovirals, Cardiovascular (CVS), Central Nervous System (CNS), Systemic Gastroenterologicals, Anti-Allergies, and Anti-Diabetics, among others. This broad therapeutic coverage underscores Aurobindo Pharma's commitment to addressing diverse healthcare needs worldwide through its extensive range of pharmaceutical solutions.

The company's operational strength lies in its integrated approach, encompassing research and development, manufacturing, and global distribution of high-quality pharmaceutical products. Aurobindo Pharma is recognized for its expertise in developing and producing complex formulations and APIs, leveraging advanced manufacturing processes. The dedicated workforce is instrumental in driving innovation and ensuring product quality and compliance across its operations; Meet Aurobindo Pharma's team to understand the expertise behind their global success. This focus on operational excellence and a skilled team enables Aurobindo Pharma to maintain a competitive edge in the pharmaceutical landscape.

With a significant global footprint, Aurobindo Pharma generates substantial revenue, reported at $3.5B, and employs a workforce exceeding 10,000 individuals across its 8 operational locations. The company's strategic market positioning and consistent growth trajectory solidify its status as a key player in the global pharmaceutical and healthcare industries. Its ticker symbol is NSE: AUROPHARMA.NS, reflecting its public market presence and financial accountability.